CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ABCLAbCellera Biologics Inc.

NASDAQ · Pharmaceutical Preparations
Last close $14.59 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$4.47B
RECENT INSIDER TRADES
  • 2026-08-24 · Hayden Michael R (Director) · BUY
  • 2026-08-18 · Montalbano John S. (Director) · BUY
  • 2026-08-14 · Booth Andrew (Chief Financial Officer) · BUY
  • 2026-08-14 · Hayden Michael R (Director) · BUY
  • 2026-08-13 · Hayden Michael R (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders157
Shares held126,597,181
Value$919.23M
Percent of shares outstanding41.29%
As of quarter end2026-06-30
RECENT NEWS
  • Abcellera Biologics stock hits 52-week high at 13.23 USD
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS